Vlad Ratziu

8PUBLICATIONS
24CO-AUTHORS
Metabolic medicinePharmacogenomicsPredictive and prognostic markersAutonomic nervous systemNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 23, 2025
Exploration of Multiple Non-Invasive Tests for Assessing Response to Treatment in a Semaglutide Phase 2b Trial in Patients with MASH.

Louise Maymann Nitze, Vlad Ratziu, Arun J Sanyal

|Oct 16, 2024
Semaglutide 2.4 mg in Participants With Metabolic Dysfunction-Associated Steatohepatitis: Baseline Characteristics and Design of the Phase 3 ESSENCE Trial.

Philip N Newsome, Arun J Sanyal, Kristiane A Engebretsen

|Dec 21, 2023
Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study.

Arun J Sanyal, Rohit Loomba, Quentin M Anstee

|Oct 03, 2023
Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis.

Stephen A Harrison, Vlad Ratziu, Quentin M Anstee

|Mar 15, 2023
Review article: The need for more efficient and patient-oriented drug development pathways in NASH-setting the scene for platform trials.

Juan M Pericàs, Nicholas A Di Prospero, Quentin M Anstee

|Mar 25, 2022
Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity score.

Rish K Pai, Vipul Jairath, Malcolm Hogan

Pageof 2